THE COMPLEMENT SYSTEM
THE COMPLEMENT SYSTEM
Class III region
¢ Between
class I and II regions is class III –contain genes coding for complement
components
¢ Complement
is a protein cascade composed of more than 40 proteins including factors
¢ Components
are made from the liver, though some local production at sites of inflammation
maybe undertaken by macrophages
Complement has 3 pathways
¢ Alternative
pathway
¢ Classical
pathway
¢ Lectin
pathway
¢ Membrane
attack pathway/common pathway
¢ The
majority of complement proteins are soluble,
some are membrane bound
¢ The
soluble proteins circulate in an inactive state, and each must be activated
sequentially for the reaction to proceed
¢ Each
activated molecules can catalyze the conversion
of several molecules of the next component in the sequence, this leads
to amplification
Complement
activation
¢ In
complement activation, classical and alternative pathways converge for the
terminal complement sequence which provides most of the biological activity
¢ The
final common pathway may be activated via classical or alternative
routes,
¢ which
are initiated by antibody –antigen complex or bacterium respectively.
CLASSICAL
PATHWAY
¢ Its
activated by an interaction between antigen and antibody to form an immune
complex
¢ The
formation of the antibody-antigen complex provokes a conformational change
in the antibody molecule that discloses a site for binding of the C1
¢ C1
is a multimeric compound composed of 6 molecules of C1q, two each of C1s
and C1r
¢ C1q
is composed of a triple helical structure and a globular head resembling a
tulip.
¢ When
antibody binds to 2 or more heads of c1q, c1r is cleaved to give an active
molecule cir, which cleaves c1s.
¢ C1s
extends the activation process by cleaving the next complement component C4 to give C4b, which
continues the reaction process, and C4a
¢ Cleavage
of C to C4b reveals an internal thioester bond, which can be inactivated
by binding water molecules unless it can form covalent bonds with
cell surface proteins or carbohydrates
¢ if
covalent bonds form, c4b becomes relatively stable and binds to C2
¢ C2
is also cleaved by c1s to form the complex C4b2a, (classical pathway C3
convertase)
¢ Cleavage of c3, results in 2 fragments. C3a and
C3b (displays binding site that allows the molecule to bind to membrane
close to.
¢ The
proximity of c3b and c4b2a leads to generation of the last enzyme
of classical pathway C4b2a3b the (c5 convertase)
LECTIN
PATHWAY
¢ The
lectin pathway is homologous to the classical pathway,
¢ This
pathway is activated by mannose-binding
lectin (MBL) - to mannose residues on the pathogen surface,
¢ MBL activates
the serine proteases to form the MBL-associated serine proteases,
MASP-1, and MASP-2 (very similar to C1r and C1s, respectively),
¢ which
can then split C4 into C4a and C4b and C2 into C2a and C2b. C4b
and C2a then bind together to form the C3-convertase, as in the classical
pathway
ALTERNATIVE
PATHWAY
¢ c3
generates c3b, c3Bb and C3bBb which cleaves c3. the
activation is accelerated if the active enzymes are stabilized on bacterial
walls or if more c3b is produced from classical pathway
¢ the
alternative pathway c5 convertase C3bBb3b is generated
¢ the
complex C3bBb3b analogues to c4b2b3b in c5 convertase which initiates the membrane
attack sequence.
MEMBRANE
ATTACK COMPLEX
¢ Cleavage
of C5 by c5 convertase gives c5a and c5b which binds to C6 and induces it to
express a reactive site for C7
¢ The
C5b67 binds to membrane.
¢ C567
has
high-affinity receptor for c8.
¢ C8
has 3 domains (α, β and γ) of inserts γ into the membrane, anchoring the c5b678
complex
¢ C5b678
binds and polymerize c9- forming the MAC.
¢ As
many12-15 C9 molecules may cluster around one c5b678 complex, inserting
into and transversing the membrane bilayer
¢ Holes
are made in the membrane and a sufficient number are created death results
trough osmotic lysis.
REGULATION OF
COMPLEMENT SYSTEM
¢ C1-inhibitor
blocks
the enzymatic function of Activated c1 by combining with it a virtually
irreversible stoichiometric complex
¢ Factor
I
– an enzyme that degrades c3b,
¢ factor
I
restrains activation of c4b(classical pathway) by destroying it.
¢ factor
H
– binds c3b and accelerates destruction
of factor I
¢ protein
s and SP-40,40 (circulating proteins)Both are able to
bind C5b67 complex to form inactive moiety, preventing membrane
insertion and formation of Mac.
¢ Carboxypeptidase
N
(circulating enzyme), it cleaves the carboxy- terminal arginine from c3a, c4a.
c5a and resulting molecules are inactivated
¢ Membrane
attack complex inhibitory factor (MACIF), interferes with the
MAC insertion, thus preventing cell
lysis.
¢ Decay
accelerating factor (DAF)- compete for C4b,thus
inhibiting formation of the classical pathway c3 convertase
¢ complement receptors (CR)
found
on the cells of the immune system
Have
restricted distribution
CR-1
to CR-4, bind breakdown products of c3
CR-1
is involved in regulation of classical pathway by binding to c4b
CR-1
enhances the action of factor I
BIOLOGICAL ACTIVITIES GENERATED BY
COMPLEMENT ACTIVATION
a) Opsonisation – proteins with opsonic activity coat bacteria or other
pathogens and facilitate their removal.
C3b
accounts for most of the complement opsonic activity,
once
organisms are coated with c3b, then CRs 1, 3 and 4 on neutrophils can result in
more efficient engulfment
b)
Cell recruitment and activation –
c4a, c3a and c5a are anaphylatoxins- mast cells and basophils are activated
through specific receptors c5a and c3a are chemotactic, ability to
attract cells e.g. neutrophils
c)
Cell lysis –
complete complement activation on cell surface lead to cell lysis of bacteria
d)
Removal of immune complexes –ab-ag
complexes increase during infection or inflammation episodes.
These are harmful because they can be deposited in vessels wall and
incite/induce complement activation
Covalent
binding of c3b to antibody in a complex inhibit lattice formation and maintains
solubility. In addition c3b-coated complexes attach to cells CR-1, a
phenomenon, immune adherence
Erythrocytes
(main cells involved) express over 85% of circulating CR-1, they act as
a buffer, constantly restoring the no. of complexes to an acceptably low level
once bound (Ag-Ab-C3b)
immune complexes are transported on cells to the liver and spleen by
erythrocytes, where they are released and taken up by resident macrophages
C-reactive protein
(CRP) –its produced in the liver and binds phosphorycholine
moieties (bacterial cell wall). when bound to cell wall, CRP activate
complement through classical pathway , independent of antibody
Comments
Post a Comment